|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 54.09 CNY | +0.32% |
|
-0.26% | +22.65% |
| 05-19 | Gan & Lee Pharmaceuticals Completes First Patient Dosing in GZR102 Trial | MT |
| 04-25 | Gan & Lee Pharmaceuticals' 2024 Profit Jumps 81%, Operating Income Rises 17%; Shares Jump 10% | MT |
EPS & Dividend: Gan & Lee Pharmaceuticals.
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | 0.2 | 1 | 0.18 | 0.24 | 0.29 |
| Rate of return | - | - | - | 0.38% | 2.27% | 0.33% | 0.44% | 0.54% |
| EPS 2 | 2.31 | 2.59 | -0.78 | 0.6 | 1.04 | 1.928 | 2.522 | 2.975 |
| Distribution rate | - | - | - | 33.3% | 96.2% | 9.34% | 9.51% | 9.75% |
| Reference price 2 | 132.22 | 70.34 | 32.58 | 52.65 | 44.10 | 54.09 | 54.09 | 54.09 |
| Nbr of stocks (in thousands) | 561,540 | 561,540 | 565,653 | 590,049 | 597,089 | 598,962 | - | - |
| Announcement Date | 14/04/21 | 27/04/22 | 30/03/23 | 24/04/24 | 24/04/25 | - | - | - |
1CNY in Million2CNY
Estimates
Past dividends: Gan & Lee Pharmaceuticals.
| 10/06/2025 | Final Payment 1 CNY |
| 01/12/2024 | Interim Payment 0.5 CNY |
| 17/06/2024 | Annual 0.2 CNY |
| 19/06/2022 | Annual 0.3 CNY |
| 20/05/2021 | Annual 0.4 CNY |
| 19/08/2020 | Annual 0.5 CNY |
Upcoming events: Gan & Lee Pharmaceuticals.
| 21/08/2025 | Q2 2025 Earnings Release (Projected) |
| 22/10/2025 | Q3 2025 Earnings Release (Projected) |
| 22/04/2026 | Q4 2025 Earnings Release (Projected) |
| 23/04/2026 | Q1 2026 Earnings Release (Projected) |
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
| 0.33% | 0.45% | 27.97x | 2.76x | 7.23x | ||
| 1.88% | 2.08% | 25.39x | 3.86x | 5.39x | ||
| -.--% | 0.01% | 51.67x | 5.74x | 12.4x | ||
| 0.86% | 0.88% | 31.16x | 2.9x | 4.71x | ||
| -.--% | -.--% | 11.16x | 0.99x | 2.18x | ||
| -.--% | 0.01% | 309.07x | 8.86x | 10.18x | ||
| - | - | 815.45x | 67.39x | 93.9x | ||
| - | - | - | - | - | ||
| -.--% | -.--% | 14.88x | 2.56x | 2.02x | ||
| 0.04% | 0.05% | 613.64x | - | - | ||
| Average | 0.39% | 0.43% | 211.16x | 11.88x | 17.25x | |
| Weighted average by Cap. | 0.77% | 0.85% | 125.27x | 8.25x | 12.46x |
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition